Pharmacologic treatment of thalassemia intermedia with hydroxyurea

Three adult patients with β-thalassemia intermedia were treated with hydroxyurea. Each had a significant but transient rise in total hemoglobin level associated with a variable increase in hemoglobin F.

Saved in:
Bibliographic Details
Published inThe Journal of pediatrics Vol. 125; no. 3; pp. 490 - 492
Main Authors Hajjar, Fouad M., Pearson, Howard A.
Format Journal Article
LanguageEnglish
Published United States Mosby, Inc 01.09.1994
Mosby-Year Book, Inc
Subjects
Administration, Oral
Adult
beta-Thalassemia - blood
beta-Thalassemia - drug therapy
Erythrocyte Indices - drug effects
Female
Fetal Hemoglobin - analysis
Hemoglobins - analysis
Humans
Hydroxyurea - administration & dosage
Hydroxyurea - therapeutic use
Male
Online AccessGet full text

Cover

More Information
Summary:Three adult patients with β-thalassemia intermedia were treated with hydroxyurea. Each had a significant but transient rise in total hemoglobin level associated with a variable increase in hemoglobin F.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-3476
1097-6833
DOI:10.1016/S0022-3476(05)83304-9